Next Generation Covid Vaccine Update: Intranasal & Other Mucosal Vaxes

0
Ad5-N Beijing Institute of Basic Medical Sciences (China) Viral vector (adenovirus) Preclinical results Ad5.SARS-CoV-2-S1 University of Pittsburgh (USA) Viral vector (adenovirus) Preclinical results
Preclinical results (vaccine adapted for variant, booster) Ad5-S-nb2 Guangzhou Institutes of Biomedicine & Health & Guangzhou nBiomed (China) Viral vector (adenovirus) Preclinical results AdC7-RBD-tr2 Organic products Chengdu Kanghua (China) Viral vector (adenovirus) Preclinical results
Preclinical results AdCoV2-S National Institutes of Health Research (Taiwan) Viral vector (adenovirus) Preclinical results BBV154 Bharat Biotech (India) Viral vector (adenovirus) Stage 1
Stage 2
Phase 2/3
Phase 3
Phase 3
(See ChAd-SARS-CoV-2-S below for preclinical) BCPIV/S-2PM BioComo (Japan) Viral vector (parainfluenza) Preclinical results BReC-CoV-2 West Virginia University (USA) Toxoid vector (diphtheria) Preclinical results ChAdOx1 nCOV-19 University of Oxford/AstraZeneca (UK) & Serum Institute of India (Covishield) Viral vector (adenovirus) Preclinical results (ferrets)
Preclinical results (hamsters, macaques)
Preclinical results (hamster)
Stage 1
Stage 1 ChAd-SARS-CoV-2-S Precision Virologics with Washington University in St Louis & NIAID (USA) Viral vector (adenovirus) Preclinical results (macaques)
Preclinical results (hamster)
Preclinical results (mouse)
(See BBV154 above for clinical trials of the Bharat version) ChAdTS-S National Institutes Food & Drug Control Beijing & West China Hospital (China) Viral vector (adenovirus) Preclinical results CNUHV03-CA22 Chungnam National University (South Korea) Live Dim Preclinical results COH04S1 City of Hope and NCI (USA) Viral vector (Modified Vaccinia Ankara) Preclinical results
(See recordings for the intramuscular version of this vaccine) CuMVTT-RBD Saiba Biotech (Switzerland) Virus-like particles Preclinical results CVXGA1 CyanVac and University of Georgia (USA) Viral vector (parainfluenza) Stage 1
Preclinical results
Preclinical results DelNS1-RBD4N-DAF University of Hong Kong (China) Viral vector (flu) Preclinical results GAM-COVID-VAC (Sputnik V) Gamaleya Research Institute (Russia) Viral vectors x 2 (adenovirus) Phase 1/2
Phase 3 (or phase 2/3 – unclear) GLS-5310 GeneOne Life Science (South Korea) DNA Stage 1 (Trials of other versions of this vaccine) ΔNA(RBD)-Influenza Fred Hutchinson Cancer Research Center and University of Washington (USA) Viral vector (flu) Preclinical results hA5-Covid-19 ImmunityBio (USA) Viral vector (adenovirus) Preclinical results
(See recordings for the intramuscular version of this vaccine) Karavac Virology Laboratory Amirabad & Institut Pasteur Tehran (Iran) Live Dim Preclinical results LP18:RBD Chinese Academy of Agricultural Sciences Changchun (China) Vector bacterium (Lactobacillus plantarum) Preclinical results MigVax-101 MigVax (Israel) Virus-like particles Preclinical results MVA-SARS-2S Hannover Institute of Immunology (Germany) Viral vector (Modified Vaccinia Ankara) Preclinical results MVC-COV1901 Medigen (Taiwan) Protein subunit Preclinical results
(See also results for the nanoemulsion adjuvant.) NanoSTING-NS University of Houston & Auravax (USA) Protein subunit Preclinical results
Preclinical results NDV-FLS University of Guelph (Canada) Viral vector (Newcastle disease virus) Preclinical results NDV-HXP-S Icahn Mt Sinai School of Medicine (USA) Viral vector (Newcastle disease virus) Stage 1
Preclinical results
(See recordings for the intramuscular form of this vaccine – see also Butanvac & Patria in this article, as well as the versions in Thailand and Vietnam) NDV-HXP-S – Butanvac Butantan Institute (Brazil) Viral vector (Newcastle disease virus) Preclinical results (See note above for other versions of NDV-HXP-S) NYVAC-KC-pfsSpike Arizona State University and University of Iowa (USA) Viral vector (NYVAC-KC) Preclinical results ODN2006 National Institute of Infectious Diseases and Tokyo University of Science (Japan) Protein subunit Preclinical results pQAC-CoV University of Wisconsin-Madison and Pan Genome Systems (USA) DNA Preclinical results rMuV-preS-6P Ohio State University (USA) Viral vector (mumps) Preclinical results rNDV-S Lancaster University and Texas Biomedical Research Institute (USA) Viral vector (Newcastle disease virus) Preclinical results (See also results for another form) rVSVSARS-CoV-2 Chinese Academy of Sciences and Biotechnology of Shenzhen Kangtai (China) Viral vector (VSV) Preclinical results SC-Ad6-1 Mayo Clinic and Tetherex Pharmaceuticals (USA) Viral vector (adenovirus) Stage 1
Preclinical results scPR8-RBD-M2 BIOTEC, NSTDA & Chulalongkorn University (Thailand) Viral vector (flu) Preclinical results T4-CoV-2 The Catholic University of America and the University of Texas (USA) Bacteriophage Preclinical results (Anonymous) Abera Bioscience (Sweden), Vrije Universiteit Amsterdam (Netherlands) & Johns Hopkins University (USA) Extracellular vesicles Preclinical results
Errata Notice (Anonymous) Academy of Military Sciences and Chinese Academy of Sciences (China) Live Dim Preclinical results (Anonymous) ACM Biolabs (Singapore) Protein subunit Stage 1
Preclinical results (Anonymous) BioTechMed-Graz & University of Graz (Austria) Extracellular Vesicles (OMVs) Preclinical results (Anonymous) FARVET, Cayetano Heredia University (Peru) Viral vector (Newcastle disease virus) Preclinical results (Anonymous) Chungbuk National University (South Korea) Protein subunit Preclinical results (Anonymous) Georgia Institute of Technology & Emory University (USA) Protein subunit Preclinical results (Anonymous) ID Pharma and National Institute of Infectious Diseases (Japan) Viral vector (Sendai F-deletion virus) Preclinical results (Anonymous) INSERM (France) & CONICET (Argentina) Virus-like particles Preclinical results (Anonymous) St. Petersburg Institute of Experimental Medicine (Russia) Viral vector (flu) Preclinical results (Anonymous) Intravacc (Netherlands) Extracellular Vesicles (OMVs) Preclinical results (Anonymous) Jeonbuk National University (South Korea) replicon mRNA Preclinical results (mouse)
Preclinical results (mouse)
Preclinical results (hamster) (Anonymous) Mahidol University & Institute of Biological Products (Thailand) Protein subunit Preclinical results
Preclinical results (Anonymous) McMaster University (Canada) Viral vector (adenovirus) Preclinical results (Anonymous) National Cancer Institute NIH (USA) Protein subunit Preclinical results
Preclinical results (booster suitable for variant) (Anonymous) National Immunological Products Engineering Research Center (China) DNA Preclinical results (Anonymous) National Institute of Allergy and Infectious Diseases (NIAID) NIH (USA) Viral vector (parainfluenza) Preclinical results
Preclinical results (pediatric primates) (Anonymous) National Institute of Allergy and Infectious Diseases (NIAID) NIH (USA) Viral vector (Modified Vaccinia Ankara) Preclinical results (Anonymous) Ohio State University (USA) Protein subunit Preclinical results (Anonymous) Oragenics and National Research Council (Canada) Protein subunit Preclinical results (Anonymous) Rutgers Cancer Institute of New Jersey (USA) Bacteriophage Preclinical results (Anonymous) Shanghai Bovax Biotech & GeneSail Biotech (China) Viral vector (adenovirus) Preclinical results (Anonymous) Sichuan University (China) Protein subunit Preclinical results
Preclinical results (Anonymous) Stanford University (USA) DNA Preclinical results (Anonymous) State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Xiamen (China) Viral vector (flu) Preclinical results (Anonymous) Sun Yat-Sen University and Chinese Academy of Sciences (China) Protein subunit Preclinical results (Anonymous) Texas Biomedical Research Institute (USA) Live Dim Preclinical results (Anonymous) TheraVectys & Pasteur Institute (France) Viral vector (Lentivirus) Preclinical results (mouse)
Preclinical results (mouse)
Preclinical results (mice, hamsters) (Anonymous) University of California, Los Angeles (UCLA) (USA) Bacteria vector (ΔcapB) Preclinical results (Anonymous) University of Hong Kong (Hong Kong) Protein subunit Preclinical results (Anonymous) University of Hong Kong (Hong Kong) Live Dim Preclinical results (Anonymous) University of Manitoba (Canada) Viral vector (recombinant VSV) Preclinical results (Anonymous) North Carolina State University, University of North Carolina and Duke University (USA) Extracellular vesicles Preclinical results (Anonymous) University of North Carolina-Chapel Hill and North Carolina State University (USA) Protein subunit Preclinical results (Anonymous) University of Texas (USA) Viral vector (parainfluenza) Preclinical results (Anonymous) University of Virginia and Mayo Clinic Viral vector (adenovirus) Preclinical results (Anonymous) University of Wisconsin-Madison (USA) Protein subunit Preclinical results (Anonymous) Vyriad & Imanis Life Sciences (United States) Viral vector (VSV) Preclinical results (Unnamed X 2) Yale University and Xanadu Bio (USA) Protein subunit and mRNA encapsulating PACE Preclinical results (Anonymous) Yunnan Key Laboratory & IMBCAMS (China) peptide Preclinical results VSV-SARS2-EBOV National Institute of Allergy and Infectious Diseases (NIAID) NIH & University of California Irvine (USA) Viral vector (VSV) Preclinical results (hamster)
Preclinical results (macaques)
Share.

Comments are closed.